| Both sides previous revision
Previous revision
Next revision
|
Previous revision
|
md_biochemistry [2026/06/26 13:25] admin |
md_biochemistry [2026/09/22 06:19] (current) resident |
| |22|:::|Instrument Purchase Vs Reagent rental/Cost per test|{{ ::2._mercury_blood_spillage.pptx |Spillage Management}} | | |22|:::|Instrument Purchase Vs Reagent rental/Cost per test|{{ ::2._mercury_blood_spillage.pptx |Spillage Management}} | |
| |23|:::|Inventory Management System|{{ ::11._qms.pptx |QMS}}| | |23|:::|Inventory Management System|{{ ::11._qms.pptx |QMS}}| |
| |23|:::|Isoenzyme|{{ ::11._qms.pptx |QMS}}| | |24|:::|Isoenzyme|{{ ::11._qms.pptx |QMS}}| |
| |24|<html><span style="font-size:150%;">Dr Arvi Mehta</span></html> |NABL-133| | |25|<html><span style="font-size:150%;">Dr Arvi Mehta</span></html> |NABL - 133|{{ ::use_and_implementation_of_nabl_symbol_as_per_nabl_-_133_in_medical_testing_laboratories.pptx |Use and Implementation of NABL Symbol as per NABL - 133 in Medical Testing Laboratories}}| |
| |25|:::| | | |26|:::|FTIR|{{ ::ftir.pptx |FTIR-Principle}}| |
| |26|:::| | | |27|:::|Quality Policy vs Quality Objective|{{ ::quality_policy_vs_quality_objective_in_context_of_iso_151892022.pptx |Quality Policy vs Quality Objective in Context of ISO 151892022}}| |
| |27|:::| | | |28|:::|VLDL Metabolism|{{ ::vldl_metabolism.pptx |VLDL Metabolism}}| |
| |28|:::| | | |29|:::|D-Dimer|{{ ::d-dimer.pptx |D-Dimer}}| |
| |29|:::| | | |
| |30|:::| | | |30|:::| | |
| |31|:::| | | |31|:::| | |
| |24|<html><span style="font-size:150%;">Dr Jahnavi Patil</span></html> |NABL-133| | |32|:::| | |
| |25|:::| | | |33|<html><span style="font-size:150%;">Dr Jahnavi Patil</span></html> |NABL-133| |
| |26|:::| | | |34|:::| | |
| | |35|:::| | |
| |27|:::| | | |27|:::| | |
| |28|:::| | | |28|:::| | |
| |28|:::|Hartnup disease|{{ ::hartnup_s_disease_-_new.pptx.pdf |}}| | |28|:::|Hartnup disease|{{ ::hartnup_s_disease_-_new.pptx.pdf |}}| |
| |29|:::|IQC|{{ ::iqc_janki.ppt.pdf |}}| | |29|:::|IQC|{{ ::iqc_janki.ppt.pdf |}}| |
| |30|:::| | | |30|:::|Risk factor of Atherosclerosis |{{ ::risk_factors_for_atherosclerosis_1_.pptx |}} | |
| |31|<html><span style="font-size:150%;">Dr Nishit Chudasama</span></html> | | | |31|:::|Prevention of Atherosclerosis |{{ ::prevention_of_atherosclerosis.pptx |}} | |
| |31|<html><span style="font-size:150%;">Dr Shivam</span></html> | | | |32|:::|Little Rascal - Lipoprotein-a |{{ ::lipoprotein_a_1_.pptx |}} | |
| | |33|:::|Mitochondrial DNA |{{ ::mitochondrial_dna.pptx |}} | |
| | |34|<html><span style="font-size:150%;">Dr Nishit Chudasama</span></html> | | |
| | |35|<html><span style="font-size:150%;">Dr Shivam</span></html> | | |
| |
| =====Model Questions List For MD Biochemistry===== | =====Model Questions List For MD Biochemistry===== |